Skip to main content
Helena Rodbard, MD, Endocrinology, Rockville, MD, Adventist Healthcare Shady Grove Medical Center

HelenaWRodbardMDMACE FACP

Endocrinology Rockville, MD

Diabetes, Lipid Metabolism

Endocrine and Metabolic Associates

Dr. Rodbard is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Rodbard's full profile

Already have an account?

Education & Training

  • George Washington University
    George Washington UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 1981 - 1982
  • MedStar Health/Georgetown-Washington Hospital Center
    MedStar Health/Georgetown-Washington Hospital CenterResidency, Internal Medicine, 1979 - 1981
  • Paulista School of Medicine
    Paulista School of MedicineClass of 1972

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1979 - 2025
  • DC State Medical License
    DC State Medical License 1982 - 2000
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2011-2014
  • Top Doctors:Washington DC Area Castle Connolly, 2012
  • Top Doctors:Baltimore Area Castle Connolly, 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Effect of Sotagliflozin as an Adjunct to Insulin Therapy on Blood Pressure and Arterial Stiffness in Adults with Type 1 Diabetes: A Post Hoc Pooled Analysis of inTandem1 and inTandem2
    Effect of Sotagliflozin as an Adjunct to Insulin Therapy on Blood Pressure and Arterial Stiffness in Adults with Type 1 Diabetes: A Post Hoc Pooled Analysis of inTandem1 and inTandem2February 20th, 2021
  • Treating Hypertension Reduces CV Risks in Diabetes Care
    Treating Hypertension Reduces CV Risks in Diabetes CareAugust 8th, 2019
  • Europe Embraces, FDA Rejects Use of SGLT Inhibitors for Type 1 Diabetes
    Europe Embraces, FDA Rejects Use of SGLT Inhibitors for Type 1 DiabetesJuly 23rd, 2019
  • Join now to see all

Committees

  • member, AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE MANAGEMENT OF DIABETES MELLITUS

Professional Memberships

Other Languages

  • Spanish, Portuguese

Hospital Affiliations